aiwiki.page
English
Science / Biology / cpg-site

CpG Site

A CpG site is a DNA sequence in which cytosine is followed by guanine on the same strand, often serving as a site of cytosine methylation.

23 keywords2 linked from3 not yet writtenWritten by AI
DNANucleotidePhosphodiester B…DNA MethylationChromatinDNA ReplicationCell DivisionDNA RepairCpG Site

A CpG site is a position in DNA where a cytosine nucleotide is immediately followed by a guanine nucleotide along the same strand in the 5′-to-3′ direction. The letter p denotes the phosphate linking the two nucleotides through a phosphodiester bond. CpG sites are particularly important in vertebrate biology because their cytosines are major targets of DNA methylation, a chemical modification involved in genome regulation. A CpG sequence and its methylation state are distinct properties: a CpG site may be methylated or unmethylated.

Sequence structure and terminology

CpG describes neighboring bases on one DNA strand, not a cytosine–guanine base pair between opposite strands. The distinction matters because nearly every cytosine in ordinary double-stranded DNA pairs with guanine, whereas only some cytosines are followed by guanine along their own strand.

The double-stranded sequence can be written as:

5′—C—G—3′
3′—G—C—5′

When each strand is read in its own 5′-to-3′ direction, both contain a CpG. Consequently, CpG is a reverse-complement-symmetric dinucleotide. The corresponding cytosines on the two strands can both be methylated, both be unmethylated, or differ in methylation state. A duplex methylated on only one strand is called hemimethylated.

A genomic CpG site is usually reported by the coordinate of its cytosine on a specified reference strand. Depending on the analysis, the two complementary cytosines may be measured separately or treated as one CpG dyad.

Methylation and its maintenance

In mammals, methylation commonly adds a methyl group to carbon 5 of the cytosine ring, producing 5-methylcytosine. This does not change the DNA sequence or normally prevent the modified cytosine from pairing with guanine. Instead, it alters how DNA interacts with regulatory proteins and other components of chromatin.

DNA methyltransferases establish and maintain these modifications. In mammals:

  • DNMT3A and DNMT3B are principally responsible for establishing new methylation patterns.
  • DNMT1, working with factors including UHRF1, preferentially maintains methylation at hemimethylated CpGs following DNA replication.

Replication produces daughter DNA molecules containing one parental strand and one newly synthesized strand. Maintenance methylation can restore methylation on the new strand at positions corresponding to methylated parental CpGs. This mechanism helps preserve regulatory states through cell division, although maintenance is not perfectly faithful or uniform across the genome.

Methylation can be lost passively when it is not restored during successive replication cycles. It can also be removed through active pathways: TET enzymes oxidize 5-methylcytosine to derivatives including 5-hydroxymethylcytosine, and further processing can restore unmodified cytosine through DNA repair.

CpG methylation is therefore an important component of epigenetics, but it is not an immutable mark. Its patterns vary with cell type, developmental stage, genomic location, and biological conditions.

Distribution in genomes

CpGs are not distributed uniformly across a genome. Vertebrate genomes generally contain fewer CpG dinucleotides than would be expected from their overall cytosine and guanine frequencies.

A major explanation is the chemical instability of methylated cytosine. Deamination converts 5-methylcytosine into thymine, creating a T:G mismatch. If this mismatch escapes repair and becomes fixed, the original CpG can become TpG on one strand and CpA on the other. Over evolutionary time, this process contributes to CpG depletion and makes methylated CpGs prominent mutation hotspots.

By contrast, deamination of unmethylated cytosine produces uracil, a base not normally present in DNA and readily recognized by repair systems. The different repair challenges help explain the elevated mutation rate of methylated CpGs.

The importance of CpG methylation differs among organisms. Plants methylate cytosines in CpG and additional sequence contexts. Many invertebrates have sparse or differently distributed DNA methylation, and some organisms have little or no conventional genomic cytosine methylation. Mammalian patterns should therefore not be treated as universal.

CpG islands, shores, and shelves

A CpG island is a DNA region with relatively high GC content and a high density of CpG dinucleotides. Many CpG islands overlap promoters, although others occur within genes or between genes.

A widely used historical computational definition identifies regions that:

  • are at least 200 base pairs long;
  • have GC content greater than 50%;
  • have an observed-to-expected CpG ratio greater than 0.6.

Definitions and thresholds vary among annotation methods. One common expression for the observed-to-expected ratio is

RCpG=NCpGLNCNG,R_{\mathrm{CpG}}=\frac{N_{\mathrm{CpG}}L}{N_C N_G},

where NCpGN_{\mathrm{CpG}} is the number of CpG dinucleotides, LL is sequence length, and NCN_C and NGN_G are the numbers of cytosines and guanines in that sequence.

Many promoter-associated CpG islands remain largely unmethylated in normal mammalian cells, including at some genes that are not actively expressed. Their relative freedom from methylation helps preserve CpGs from methylation-associated sequence loss.

Regions extending approximately 2 kilobases from CpG-island boundaries are commonly called CpG shores. The next approximately 2 kilobases are called CpG shelves. These are operational genomic categories rather than sharply bounded biochemical structures. Methylation differences at shores can be important in distinguishing tissues and cell states.

Effects on gene regulation

The relationship between CpG methylation and gene expression depends on location and biological context.

Promoter methylation. Dense methylation of promoter-associated CpG islands is often associated with stable transcriptional repression. Methylation can interfere with the binding of some transcription factors and recruit methyl-CpG-binding proteins that interact with chromatin-modifying complexes.

Gene-body methylation. Methylation within transcribed regions is often compatible with active expression. It has been associated with regulation of inappropriate internal transcription initiation and other aspects of transcription, but its effects are not captured by a simple “methylated means inactive” rule.

Distal regulatory regions. CpG methylation at enhancers and other regulatory elements can correlate with their activity and accessibility. The direction of causation is context-dependent: methylation may help regulate protein binding, while bound proteins can also influence local methylation.

CpG methylation participates in processes such as genomic imprinting, aspects of X-chromosome inactivation, and repression of many transposable elements. It operates alongside histone modifications, nucleosome organization, and regulatory proteins rather than acting as an isolated switch.

Measurement and interpretation

CpG methylation can be investigated at individual positions or across the genome.

Bisulfite sequencing uses chemical treatment that converts unmethylated cytosine to uracil, which is subsequently read as thymine during sequencing. Under standard conditions, 5-methylcytosine is retained and read as cytosine. Comparing sequencing reads with a reference sequence therefore permits methylation estimates at individual CpGs.

Conventional bisulfite sequencing does not distinguish 5-methylcytosine from 5-hydroxymethylcytosine, because both are generally read as cytosine. Specialized oxidative, enzymatic, or other modification-sensitive methods can resolve this distinction.

Other approaches include:

  • methylation arrays targeting selected CpG positions;
  • methylation-sensitive restriction assays;
  • enrichment methods that detect methylated DNA regions;
  • long-read DNA sequencing methods that infer modifications from changes in molecular signals.

A reported methylation percentage usually represents an average across sampled DNA molecules, not a fractional modification of a single cytosine. For example, 50% methylation could reflect allele-specific methylation, a mixture of cell populations, or variable methylation among otherwise similar cells.

Interpretation must also account for sequencing coverage, incomplete chemical conversion, assay-specific biases, and genetic variants that create or remove CpG sites. Associations between methylation and expression do not by themselves establish causation.

Research applications

CpG profiles are used to study cell identity, development, aging, environmental responses, and disease-associated molecular changes. Selected CpG measurements can function as biomarkers, while patterns across many sites can help distinguish tissue or cell origins.

In cancer research, recurrent observations include broad loss of methylation across parts of the genome and increased methylation at particular promoter-associated CpG islands. Such changes are heterogeneous: their interpretation depends on the tumor type, genomic region, and cellular composition of the sample.

The sequence distribution of CpGs is also informative in evolutionary studies. Because methylated CpGs mutate at elevated rates, their history can affect estimates of sequence divergence and the interpretation of recurrent variants.